Skip to main content
Premium Trial:

Request an Annual Quote

Compugen Opens New Israeli Ag-Bio Division

NEW YORK, Jan. 30 - Compugen has launched an agricultural biotech and plant genomics subsidiary charged with the humble task of accelerating and directing the process of evolution.

 

The new subsidiary, Agro-LEADS, continues Compugen's efforts to integrate computational biology and plant genomics with traditional agricultural techniques, Compugen said on Wednesday.

 

Based in Rehovot, Israel, Agro-LEADS will focus on developing seeds with improved traits. It also plans collaborations with outside researchers in crop protection, nutritionally improved crops, and the expression of therapeutic and industrial products in genetically engineered plants.

 

The subsidiary will be co-managed by Hagai Karchi and Rafael Meissner, who are also co-founders. Their team includes plant geneticists, bioinformaticists, molecular biologists, and traditional plant breeders.

 

Compugen is a publicly owned Israeli bioinformatics company.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.